Hexaminolevulinate Withdrawn Phase 4 Trials for Bladder Cancers Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT00785694Recurrence of Bladder Cancer After Transurethral Resection With Hexvix